Literature DB >> 7512063

Origin and development of exocrine pancreatic insufficiency in experimental renal failure.

M M Lerch1, P Hoppe-Seyler, W Gerok.   

Abstract

Chronic renal failure affects the physiological function of many organ systems. One of them is the exocrine pancreas. Although varying degrees of pancreatic insufficiency are the dominating clinical characteristic of uraemic pancreatic disease, it remains unclear whether this disease should be regarded as a manifestation of chronic pancreatitis, arising from recurring attacks of acute pancreatitis, or represents a distinct entity. The exocrine pancreas was studied in a model of experimental renal failure. The pancreas was removed from each rat at selected time points over eight weeks after subtotal nephrectomy and from a standard rat model of pancreatitis for comparison. The data show that the in vitro secretory response is considerably changed in renal failure (increased during early acute and decreased during chronic renal failure). While the pancreatic content of digestive enzymes progressively declines, DNA and protein synthesis increase over time. Acinar cell deletion is increased and accompanied by an increased rate of mitosis. This increased cellular turnover is not associated with tissue oedema, pancreatic fibrosis, inflammatory changes, autophagocytosis or subcellular redistribution of lysosomal hydrolases, all of which are characteristic for pancreatitis. The ultrastructural changes of uraemic pancreatic disease bear no resemblance to the changes seen in pancreatitis. It is concluded that the morphological and biochemical changes in early uraemic pancreatic disease are quite distinct, correspond with toxic damage of the pancreas, and are dominated by functional impairment and an increased cellular turnover.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512063      PMCID: PMC1374599          DOI: 10.1136/gut.35.3.401

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Experimentally induced chronic renal insufficiency in the rat.

Authors:  A B MORRISON
Journal:  Lab Invest       Date:  1962-04       Impact factor: 5.662

2.  Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model.

Authors:  J Floege; C E Alpers; M W Burns; P Pritzl; K Gordon; W G Couser; R J Johnson
Journal:  Lab Invest       Date:  1992-04       Impact factor: 5.662

3.  A plasma protease which is expressed during supramaximal stimulation causes in vitro subcellular redistribution of lysosomal enzymes in rat exocrine pancreas.

Authors:  M Saluja; A Saluja; M M Lerch; M L Steer
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

4.  Pancreatic pathology in chronic dialysis patients--an autopsy study of 78 cases.

Authors:  N D Vaziri; B Dure-Smith; R Miller; M Mirahmadi
Journal:  Nephron       Date:  1987       Impact factor: 2.847

5.  Supramaximal caerulein stimulation and ultrastructure of rat pancreatic acinar cell: early morphological changes during development of experimental pancreatitis.

Authors:  O Watanabe; F M Baccino; M L Steer; J Meldolesi
Journal:  Am J Physiol       Date:  1984-04

6.  A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections.

Authors:  A López-De León; M Rojkind
Journal:  J Histochem Cytochem       Date:  1985-08       Impact factor: 2.479

7.  Association between acute pancreatitis and malignant hypertension with renal failure.

Authors:  C G Barcenas; M Gonzalez-Molina; A R Hull
Journal:  Arch Intern Med       Date:  1978-08

8.  Alteration of membrane fusion as a cause of acute pancreatitis in the rat.

Authors:  G Adler; G Rohr; H F Kern
Journal:  Dig Dis Sci       Date:  1982-11       Impact factor: 3.199

9.  Effects of in vivo cholinergic stimulation of rat exocrine pancreas.

Authors:  G Adler; G Gerhards; J Schick; G Rohr; H F Kern
Journal:  Am J Physiol       Date:  1983-06

10.  Pancreatic exocrine function in severe human chronic renal failure.

Authors:  C Owyang; L J Miller; E P DiMagno; J C Mitchell; V L Go
Journal:  Gut       Date:  1982-05       Impact factor: 23.059

View more
  7 in total

Review 1.  Gastrointestinal function in chronic renal failure.

Authors:  A M Ravelli
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

2.  Vasoactive mediators and the progression from oedematous to necrotising experimental acute pancreatitis.

Authors:  H Weidenbach; M M Lerch; T M Gress; D Pfaff; S Turi; G Adler
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

3.  Low serum pancreatic enzyme levels predict mortality and are associated with malnutrition-inflammation-atherosclerosis syndrome in patients with chronic kidney disease.

Authors:  Abdullah Ozkok; Omer Celal Elcioglu; Tahsin Cukadar; Ali Bakan; Gulsah Sasak; Kadir Gokhan Atilgan; Sabahat Alisir; Mehmet Kanbay; Adrian Covic; Ali Riza Odabas
Journal:  Int Urol Nephrol       Date:  2012-08-02       Impact factor: 2.370

Review 4.  Do Animal Models of Acute Pancreatitis Reproduce Human Disease?

Authors:  Fred S Gorelick; Markus M Lerch
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-06-10

Review 5.  Murine Models of Acute Pancreatitis: A Critical Appraisal of Clinical Relevance.

Authors:  Pedro Silva-Vaz; Ana Margarida Abrantes; Miguel Castelo-Branco; António Gouveia; Maria Filomena Botelho; José Guilherme Tralhão
Journal:  Int J Mol Sci       Date:  2019-06-07       Impact factor: 5.923

Review 6.  Pancreatic involvement in patients with inborn errors of metabolism.

Authors:  Woo Jin Hwang; Han Hyuk Lim; Yoo-Mi Kim; Mea Young Chang; Hong Ryang Kil; Jae Young Kim; Wung Joo Song; Harvey L Levy; Sook-Za Kim
Journal:  Orphanet J Rare Dis       Date:  2021-01-20       Impact factor: 4.123

7.  Tempol, a Membrane-Permeable Radical Scavenger, Exhibits Anti-Inflammatory and Cardioprotective Effects in the Cerulein-Induced Pancreatitis Rat Model.

Authors:  Andrzej Marciniak; Beata Walczyna; Grażyna Rajtar; Sebastian Marciniak; Andrzej Wojtak; Katarzyna Lasiecka
Journal:  Oxid Med Cell Longev       Date:  2015-12-07       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.